Terumo Cardiovascular Group is a Michigan-based healthcare company that designs, manufactures, and distributes devices for cardiovascular-related surgeries. It conducts its operations throughout the United States, Asia, and Europe.
The company offers multiple products for surgical purposes such as autotransfusion products, endoscopic products, heart-lung machines, oxygenation systems and monitoring systems. Its products are available for use in a hospital or professional medical setting.
Terumo Cardiovascular Group has oxygenation systems that could aid COVID-19 patients. One such system, the Prescriptive Oxygenation, is a small to mid-sized system that can match the needs of certain patients based on their body surface area. It is highlighted for its ability to conserve blood in a medical context.
Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke
Terumo Cardiovascular Group
April 6, 2017
Documentaries, videos and podcasts
- Cluster: COVID-19A cluster of topics related to COVID-19. COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the WHO.